The Latest Cardiac and Vascular News
April 20, 2022 New research proposes a four-stage system for measuring the progression of cardiovascular disease (CAD) based on atherosclerotic plaque – not secondary symptoms of heart disease. Quantification of CAD burden and plaque type has demonstrated to be the strongest discriminant of future risk of Major Adverse Cardiac Events […]
Findings from Cleerly’s groundbreaking CLARIFY 2 study echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease evaluation. The study, the second of six studies comparing Cleerly analysis against current gold standards to plaque and coronary artery imaging, demonstrates Cleerly’s effectiveness in the identification and exclusion of […]
Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced its latest product release, Cleerly 2.2.0, that includes user experience (UX) refinements and three new high-value tools. These updates come in […]
Organization recognizes the most promising and innovative health startups in New York NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway to New York’s healthcare ecosystem, has recognized the company on […]
NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced today it has expanded its board of directors with three new medical and investment leaders. Kevin M. King, Glenn D. Steele Jr., MD, PhD and Roy Beveridge MD have joined the board to advise the […]
Sales strategy expert brings industry success to leverage growth. NEW YORK – October 18, 2021 – Cleerly, the company creating a new standard of care for heart disease, announced today it has appointed Jim Hartman as Chief Revenue Officer. In this role, Jim will be responsible for driving the company’s […]
Brandon Atkinson joins as COO and Nick Nieslanik as CTO to Support Company’s Mission to Create a New Standard of Care for Heart Disease, the Leading Cause of Death. NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced today it has appointed Brandon Atkinson […]
The collaboration breaks new ground by integrating Canon’s AI-powered CT technology with Cleerly’s digital pathway solution for analysis of coronary artery disease. TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical Systems, USA joins forces with Cleerly in a strategic partnership to support simple and streamlined adoption of cardiac CT and create a new standard […]
Resulting from More than a Decade of Clinical Research, Company Unveils Non-Invasive Approach to Identify, and New Care Pathways to Address Heart Disease Using Artificial Intelligence NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, launched today with $43 million in Series B funding and […]
